天津发展(00882.HK)附属力生制药拟出资1.74亿元参与设立基金

智通财经
Sep 10, 2025
【天津发展(00882.HK)附属力生制药拟出资1.74亿元参与设立基金】智通财经APP讯,天津发展(00882.HK)发布公告,于2025年9月10日,力生制药(本公司间接非全资附属公司)与建信股权、泰达私募、共青城建兴、泰达国际、国资母基金及战新基金订立合伙协议,该基金将以人民币5亿元(相当于约港币5.47亿元)的认缴出资总额设立,其中,力生制药(作为有限合伙人)已向该基金认缴出资人民币1.74亿元(相当于约港币1.9亿元),占该基金认缴出资总额的34.75%,惟须受合伙协议的条款及条件所规限。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10